Navigation Links
Sanarus Technologies Appoints Richard A. Stark to President
Date:8/7/2018

BJ Hardman, Chief Executive Officer, today announced the appointment of Richard A. Stark to assume the role of Sanarus Technologies President, effective immediately. Mr. Stark will lead all company operations and will apply his 20+ years of strategic development, marketing and sales experience in medical device toward finding new and innovative ways to advance market adoption, help customers, increase funding activities, and drive product utilization globally.

“I’m pleased to have the opportunity to lead this innovative technology company which is pioneering a minimally invasive cryoablation procedure in the breast cancer market,” said Mr. Stark. “I look forward to bringing this safe and effective procedure to patients around the globe.” 

Mr. Stark’s recent role as Senior Vice President, General Manager at AngioDynamics, resulted in him being instrumental in the development and commercialization of the company’s oncology strategy. From 2008 to 2012, he served as Vice President of Sales and Marketing, General Manager for the company’s oncology/surgery division before being promoted in 2012 to Senior Vice President, General Manager. He has extensive experience in shaping corporate strategy and is skilled in all aspects of corporate startup, growth, and acquisition. Prior to his tenure at AngioDynamics, he was Vice President of US Sales for RITA Medical and was instrumental in the sale of the company to AngioDynamics. He has also held field sales positions at Woodside Biomedical and Arrow/Teleflex. Mr. Stark joined the Board of Directors of Sanarus Technologies in 2016, and has worked alongside Dr. Govindarajan “Raj” Narayanan, Charles Berolzheimer, Lee Story, Matt Nalipinski, Sharon Maher, Heather Simonsen and BJ Hardman.
 
“We are thrilled to have Rick Stark lead the Sanarus Technologies team,” said Mrs. Hardman, Chief Executive Officer and Chairman. “Rick has years of success in start-ups and large corporations, and we look forward to the leadership he brings as we continue to increase adoption of the Visica® 2 Treatment System.”
 
The Visica 2 Treatment System is a minimally invasive alternative to lumpectomy or mastectomy. The patented, FDA-cleared system utilizes extreme cold to immediately kill cancerous tumors in a doctor’s office. An ultrasound-guided probe is inserted into the tumor under local anesthetic. An ice ball forms concentrically around the tumor, killing it immediately and the clean margins are detected real time via ultrasound. In less than 30 minutes of procedure time, the tumor is completely destroyed with virtually no scarring or cosmetic damage. Compared to lumpectomy or mastectomy, the Visica 2 Treatment System significantly reduces overall healthcare costs associated with operating room based surgical procedures as it negates the need for the use of an operating room, surgical revisions, or breast reconstruction.

About Sanarus Technologies, Inc. 
In 2001, the Visica® Treatment System was the first system available for cryoablation of breast fibroadenomas. Since then, our systems have been used to successfully treat thousands of patients. The System is FDA-cleared for the ablation of cancerous or malignant tissue and benign tumors. With Sanarus’ invention of liquid nitrogen-based cryoablation in 2006, the Visica 2 Treatment System has been used to treat cancer in cryoablation-assisted surgeries and cryoablation-only procedures in clinical trials. At Sanarus, we pride ourselves in developing innovative solutions for the nonsurgical treatment of breast tumors. We are a majority woman-owned business, headquartered in Pleasanton, CA, and all our products are manufactured in the USA. Find out more at http://www.sanarus.com.

Read the full story at https://www.prweb.com/releases/sanarus_technologies_appoints_richard_a_stark_to_president/prweb15673048.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
2. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
3. Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico
4. Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria
5. Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio
6. Global Markets and Technologies for Optical Coherence Tomography (OCT)
7. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
8. BioSpecifics Technologies Corp. to Present at Jefferies 2013 Global Healthcare Conference
9. Breathe Technologies Sleep System Receives FDA Clearance
10. Finalists Announced for Israel Brain Technologies Million Dollar Global B.R.A.I.N. Prize
11. Frost & Sullivan Market Share Leadership Award Highlights Acuo Technologies Accomplishments in Enterprise Imaging Informatics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2019)... NEW YORK (PRWEB) , ... June 20, 2019 ... ... showed signs that exposure to dust from the World Trade Center site had ... according to a study by Mount Sinai researchers in Molecular Cancer Research in ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... clinical trials, today announced its scientific and technological experts will present a series ... Information Association (DIA) Annual Meeting in San Diego, June 23-27. , ERT’s ...
(Date:6/20/2019)... N.C. (PRWEB) , ... June 20, 2019 , ... ... (SCTM) demonstrates how preconditioning mesenchymal stem cells (MSCs) enhances their ability to treat ... to developing more effective MSC treatments for clinical application, according to Ben Antebi, ...
Breaking Medicine Technology:
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... ... adolescents and adults, today announced the restructuring of the Strategic Advisory Board (SAB) ... to meet the demand for behavioral health care. , We are ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... IT services, announced that Angel Rosa has been appointed as Senior Vice President ... developing and implementing new services, growing and nurturing high performing teams, and driving ...
(Date:6/20/2019)... ... , ... The 2019 Colorado Classic® presented by VF Corporation will showcase its ... elite teams, organizers announced today. The top-four domestic teams in USA Cycling’s Pro ... , The standalone pro women’s road race has received commitments from 16 teams, ...
(Date:6/19/2019)... ... ... CEO Steven C. Bilt of Smile Brands Inc. has won a Glassdoor ... , one of the world’s largest job and recruiting sites, released its annual report ... throughout North America and parts of Europe. , Smile Brands, a leading dental support ...
(Date:6/19/2019)... ... June 19, 2019 , ... The FSH Society announced ... in Marseille, France. The conference is widely seen as the premier global platform ... Nearly 200 researchers, clinicians, industry representatives and patient advocates are attending. , Researchers ...
Breaking Medicine News(10 mins):